Press "Enter" to skip to content

Ibrutinib Shown to Cross the Blood-Brain Barrier in CNS Lymphoma – Cancer Therapy Advisor

admin 0

Ibrutinib Shown to Cross the Blood-Brain Barrier in CNS Lymphoma  Cancer Therapy Advisor

The results of a prospective, multicenter, phase 2 study of patients with relapsed or refractory primary central nervous system (CNS) lymphoma or primary …

“lymphoma cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *